PRECIGEN, INC. — Director's Dealing 2014

Jan 8, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INTREXON CORP (XON)
CIK: 0001356090
Period of Report: 2014-01-06

Reporting Person: Frost Gregory Ian (SVP--Health Sector)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-01-06	Option to Purchase Common Stock	$22.77	A	1000000	Acquired	2024-01-06	Common Stock (1000000)	Direct

Footnotes

F1: These options vest annually in increments of 250,000 per year on each of January 6, 2015, 2016, 2017 and 2018, respectively.